Race is pleased to announce the appointment of global pharmaceutical and commercial leader, Mr Damian Clarke-Bruce, as Managing Director and Chief Executive Officer, effective 1 February 2023. Mr Phil Lynch…

Race-Submits-Human-Ethics-Application-to-Commence-Cardioprotection-Breast-Cancer-TrialDownload

Danny-Sharp-appointed-an-Independent-Non-Executive-Director-of-RaceDownload

Race Oncology 2022 AGM Presentation by CEO Phil Lynch and CSO Dr Daniel Tillett. https://youtu.be/sIgOxKGC6Cg

Race-Receives-Positive-Guidance-on-Zantrene-via-Pre-IND-Meeting-with-US-FDADownload